Merck reported higher third-quarter profit and boosted its full-year outlook, as demand for its flagship Keytruda cancer drug ...

Merck reported higher third-quarter profit and boosted its full-year outlook, as demand for its flagship Keytruda cancer drug continues to rise. The pharmaceutical company reported net income of $5.79 ...

(Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced ...

The Western Cape Department of Health and Wellness is calling on all parents and caregivers to ensure their children are fully immunised as the province prepares to launch its National Immunisation ...

The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity ...

"It wasn’t until I developed a random blind spot in my eye that my mom took me to the ER. They ordered a head CT that caught ...

Subcutaneous RYBREVANT®▼ (amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer ...

Crisis pregnancy centers, or anti-abortion organizations that try to prevent customers from accessing abortion and ...

The Western Cape Department of Health and Wellness is calling on all parents and caregivers to ensure their children are ...

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability In Oncology - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 27, 2025 – The global ...

A notice of Motion, expressing solidarity with the ‘Ladies with Letters’ campaign group, and calling for a public enquiry to ensure that ...

Our experts dissect the NHS planning guidance for 2026/7 to 2028/29, and ask what it means for the system, staff and patients ...